Organigram gets Health Canada OK to expand cultivation
Organigram Holdings Inc., a licensed producer of medical marijuana based in Moncton, N.B., has received an expanded cultivation license from Health Canada related to its previously announced Phase 3 expansion.
June 5, 2018 By Grow Opportunity staff
The scope of the amendment includes approval of the following:
- The entire perimeter of the expanded facility, approximately 40,000 sq ft;
- The first six of Organigram’s new 16 three-tier cultivation rooms in the Phase 3 expansion; and
- Refined functional design on an already improved Phase 2 design including slightly higher grow rooms and the location of HVAC units entirely on the outside of the rooms for enhanced ergonomics and improved airflow.
As a result of this approval, cannabis plants will be moved into these new rooms on a rolling basis beginning June 6, 2018. The company will be able to begin staggered harvests from these new rooms by the first week in August. The remaining ten Phase 3 rooms are expected to come online on or before June 30, 2018 in stages pending Health Canada approval, Organigram said.
Organigram also notes that this licensing does not require a new sales license and there will be no delay from harvest to sale.
Once the remaining Phase 3 rooms are online the company will have a target production capacity of 36,000 kg/year of dried flower equivalent.
“Based on our review of publicly available data we believe we will be one of the top 5 licensed producers in terms of current production capacity once the remaining rooms from Phase 3 are approved,” said Greg Engel, CEO. “Given our existing inventory, production volume and consistency and quality of supply, we believe we are well positioned to be a supplier of choice for many of the provincial cannabis boards and private retailers across Canada.”
Print this page